NICE guideline [NG203]: Chronic kidney disease — assessment and management

The updated NICE chronic kidney disease guideline (NG203) shifts to a risk-based referral approach using the Kidney Failure Risk Equation and recommends adding an SGLT2 inhibitor to ACE-inhibitor or ARB therapy for eligible patients with type 2 diabetes and significant albuminuria.